Results 41 to 50 of about 2,408 (188)

Intranasal melanoma treated with radiation therapy in three dogs [PDF]

, 2017
Three dogs were investigated for chronic unilateral nasal discharge. In all cases CT imaging showed an intranasal mass causing turbinate lysis and no evidence of metastasis.
Blackwood, L, Davies, O, Holmes, E, Lara-Garcia, A, Necova, S, Spencer, S, Taylor, A   +6 more
core   +4 more sources

Olfactory neuroblastoma: diagnosis, management, and current treatment options

Frontiers in Oncology, 2023
Olfactory neuroblastoma (ONB) is a rare neoplasm originating from the olfactory neuroepithelium representing 3-6% of tumors of the sinonasal tract. ONB require multi-disciplinary care.
Alicia Tosoni, Vincenzo Di Nunno, Lidia Gatto, Giacomo Corradi, Stefania Bartolini, Lucia Ranieri, Enrico Franceschi   +6 more
doaj   +1 more source

Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management [PDF]

, 2013
Neuroendocrine tumours (NETs) of the head and neck are rare neoplasms and can be of epithelial or non-epithelial differentiation. Although the natural history of NETs is variable, it is crucial to establish an early diagnosis of these tumours as they can
Chowdhury, F, Patel, C, Prestwich, R, Scarsbrook, A, Subedi, N   +4 more
core   +1 more source

Ectopic primary olfactory neuroblastoma of the nasopharynx: A case report and review of the literature

Radiology Case Reports, 2019
Olfactory neuroblastoma (ONB, also called esthesioneuroblastoma) is a rare malignant tumor of neuroectodermal olfactory cells. We report a case of an undifferentiated ONB with unfavorable histology arising ectopically in the nasopharynx.
Nicholas J. Caldwell, BS, T. Shawn Sato, MD   +1 more
doaj   +1 more source

Management of Esthesioneuroblastoma: A Retrospective Study of 6 Cases and Literature Review

Case Reports in Oncology, 2022
The esthesioneuroblastoma (ENB) is a rare malignant sinonasal tumor of neuroectodermal origin. This study aimed to improve the understanding of the clinical features by reviewing the literature and analyzing the medical records of patients diagnosed with
Zenab Alami, Fatima Zahrae Farhane, Amina Bouziane, Samiya Mhirech, Sara Amrani Joutei, Wissal Hassani, Touria Bouhafa   +6 more
doaj   +1 more source

Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review

World Journal of Otorhinolaryngology-Head and Neck Surgery, 2022
Background Historically sinonasal malignancies were always addressed via open craniofacial surgery for an oncologic resection. Increasingly esthesioneuroblastomas are excised using an exclusively endoscopic approach, however, the rarity of this disease ...
Daniel B. Spielman, Andi Liebowitz, Maeher Grewal, Chetan Safi, Jonathan B. Overdevest, Alfred M. Iloreta, Brett E. Youngerman, David A. Gudis   +7 more
doaj   +1 more source

Olfactory Neuroblastoma: Re-Evaluating the Paradigm of Intracranial Extension and Cyst Formation

Diagnostics, 2022
The purpose of the current study was to assess the prevalence of cyst formation at the brain-tumor interface in olfactory neuroblastoma. We used the UCLA patient-based Pathology and Radiology Head and Neck Database (UPP&R HAND) to identify the largest ...
Rebecca A. Dumont, Miguel Fernando Palma Diaz, William Hsu, Ali R. Sepahdari   +3 more
doaj   +1 more source

Bilayer Button Graft for Endoscopic Repair of High-Flow Cranial Base Defects [PDF]

, 2015
Closure of dural defects in trans-nasal, extended, endoscopic techniques remains a challenge, and published cerebrospinal fluid (CSF) leak rates are higher than rates for trans-cranial approaches.
Evans, J. J., Farag, A. A., Farrell, C., Luminais, Chris, Mohiuddin, W., Nyquist, G. G., Otten, M. L., Rosen, M. R., Soni, P., Ziegler, N.   +9 more
core   +2 more sources

Esthesioneuroblastoma

Neurosurgery, 1993
Forty-nine patients with esthesioneuroblastoma were treated at the Mayo Clinic between 1951 and 1990. Their clinical manifestations and treatment results were reviewed to identify possible prognostic factors. The 5-year survival rate for all patients was 69%.
A, Morita, M J, Ebersold, K D, Olsen, R L, Foote, J E, Lewis, L M, Quast   +5 more
openaire   +3 more sources

Intensity modulated radiotherapy (IMRT) in the treatment of children and Adolescents - a single institution's experience and a review of the literature [PDF]

, 2009
Background While IMRT is widely used in treating complex oncological cases in adults, it is not commonly used in pediatric radiation oncology for a variety of reasons. This report evaluates our 9 year experience using stereotactic-guided, inverse planned
Florian Sterzing, Eva M Stoiber, Simeon Nill, Harald Bauer, Peter Huber, Jürgen Debus, Marc W Münter, Intensity Modulated Radiation Therapy Collaborative Working Group, A Eisbruch, C Nutting, A Pirzkall, W Zhen, MW Munter, D Schulz-Ertner, MW Munter, SL Wolden, G Studer, ML Cavey, M Guckenberger, L Veldeman, F Sterzing, A Boyer, TR Mackie, EJ Hall, EJ Hall, SF Kry, U Schneider, M Mazonakis, B Rhein, A Bhatnagar, JA Penagaricano, AC Paulino, BS Teh, JA Penagaricano, E Huang, N Jain, MJ Krasin, TM Schroeder, MW McDonald, AE Curtis, SE Combs, S Laskar, RB Kuppersmith, M Fuss, D Verellen, M Koshy, JS Welsh, EJ Hall, J Blatt, DG Gold, AC Paulino, HM Lin, LL Robison, GT Armstrong, F Nguyen, W Dorr, W Parker, A Rembielak   +57 more
core   +1 more source